abstract |
The present invention relates to a method for determining the potential of pharmaceutical substances to lower the cellular glutathione content and / or to increase the cellular ROS content; The substances identified in this way, which lower the cellular GSH level, can be used to treat T-cell-mediated autoimmune diseases. |